Form 8.3 - AON PLC

Form 8.3 - AON PLC

BARCLAYS PLC

 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in AON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 18 September 2020

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)

(1)

Relevant securities

390,546

0.17%

2,380,359

1.03%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

530,855

0.23%

28,200

0.01%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

107,299

0.05%

106,599

0.05%

 

 

 

 

TOTAL:

 

 

 

 

1,028,700

0.44%

2,515,158

1.09%

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit

Purchase

6

201.3750 USD

Purchase

33

202.9500 USD

Purchase

50

202.2740 USD

Purchase

80

201.8900 USD

Purchase

93

202.8500 USD

Purchase

100

201.3450 USD

Purchase

100

202.0800 USD

Purchase

153

202.5716 USD

Purchase

576

201.0643 USD

Purchase

798

201.2755 USD

Purchase

911

201.9307 USD

Purchase

1,654

201.4701 USD

Purchase

2,230

201.9793 USD

Purchase

2,248

201.8206 USD

Purchase

4,661

201.9864 USD

Purchase

5,461

201.6197 USD

Purchase

13,992

201.0896 USD

Purchase

14,804

201.0000 USD

Purchase

20,844

202.2956 USD

Purchase

21,098

201.2564 USD

Purchase

33,475

202.1010 USD

Sale

3

202.9400 USD

Sale

6

201.3750 USD

Sale

8

202.3000 USD

Sale

8

203.2300 USD

Sale

9

202.2700 USD

Sale

12

203.2966 USD

Sale

22

201.3400 USD

Sale

35

202.6400 USD

Sale

35

201.6640 USD

Sale

41

201.6187 USD

Sale

56

202.7650 USD

Sale

56

202.7212 USD

Sale

65

202.2400 USD

Sale

90

201.1300 USD

Sale

100

203.1200 USD

Sale

100

203.1800 USD

Sale

100

203.0400 USD

Sale

100

203.0100 USD

Sale

100

202.9100 USD

Sale

100

202.7600 USD

Sale

100

202.6500 USD

Sale

107

202.1901 USD

Sale

154

202.5245 USD

Sale

161

202.0765 USD

Sale

182

202.0000 USD

Sale

200

201.9150 USD

Sale

200

201.2500 USD

Sale

201

202.4790 USD

Sale

210

202.2270 USD

Sale

212

201.7900 USD

Sale

245

202.1655 USD

Sale

259

202.3191 USD

Sale

300

202.7583 USD

Sale

300

202.9800 USD

Sale

300

201.4033 USD

Sale

308

202.2861 USD

Sale

374

202.3532 USD

Sale

400

202.3875 USD

Sale

409

202.1568 USD

Sale

500

202.3420 USD

Sale

586

202.7522 USD

Sale

610

202.3645 USD

Sale

695

201.1080 USD

Sale

748

202.5049 USD

Sale

797

201.4419 USD

Sale

1,100

202.3818 USD

Sale

1,468

202.1931 USD

Sale

1,800

201.5636 USD

Sale

2,167

202.0942 USD

Sale

2,690

202.3502 USD

Sale

3,261

201.0234 USD

Sale

4,194

202.0226 USD

Sale

4,283

201.0000 USD

Sale

4,919

200.9573 USD

Sale

5,362

201.3011 USD

Sale

6,905

202.4655 USD

Sale

7,742

202.3317 USD

Sale

10,422

202.2956 USD

Sale

17,116

201.3494 USD

Sale

17,668

201.8022 USD

Sale

21,098

201.2564 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing
and any other person relating to the voting rights of any relevant securities under any option
referred to on this form or relating to the voting rights or future acquisition or disposal of any
relevant securities to which any derivative referred to on this form is referenced. If none, this
should be stated.
NONE
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure:

21 Sep 2020

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates

Call Options

Purchased

700

195.0000

American

Sep 18, 2020

Put Options

Purchased

-106,599

214.5780

European

Oct 20, 2020

Put Options

Written

106,599

214.5780

European

Oct 20, 2020

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

UK 100

Latest directors dealings